Filing Details
- Accession Number:
- 0000950142-15-002621
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-15 18:28:21
- Reporting Period:
- 2015-12-11
- Filing Date:
- 2015-12-15
- Accepted Time:
- 2015-12-15 18:28:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1581720 | Loxo Oncology Inc. | LOXO | Pharmaceutical Preparations (2834) | 462996673 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1172252 | N Andrew Schiff | 888 Seventh Avenue, 12Th Floor New York NY 10106 | No | No | Yes | No | |
| 1250195 | Steve Elms | 888 Seventh Avenue 12Th Floor New York NY 10106 | Yes | No | Yes | No | |
| 1297291 | J Dennis Purcell | 888 Seventh Avenue, 12Th Floor New York NY 10106 | No | No | Yes | No | |
| 1444717 | Aisling Capital Iii Lp | 888 Seventh Avenue, 12Th Floor New York NY 10106 | No | No | Yes | No | |
| 1532634 | Aisling Capital Partners Iii Lp | Aisling Capital Llc 888 Seventh Avenue 12Th Floor New York NY 10106 | No | No | Yes | No | |
| 1532635 | Aisling Capital Partners Iii Llc | Aisling Capital Llc 888 Seventh Avenue 12Th Floor New York NY 10106 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-11 | 200 | $27.50 | 3,796,362 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The securities are directly held by Aisling Capital III, LP ("Aisling"), and indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Mr. Elms is a member of the Issuer's Board of Directors. Dr. Joshua Bilenker, the Issuer's President and Chief Executive Officer, is a member of the Issuer's Board of Directors and an Operating Partner of Aisling GP. Mr. Elms is a member of the investment committee (the "Investment Committee") of Aisling GP. The Investment Committee has voting and dispositive power over the shares held by Aisling.
Billionaire Hedge Funds
